India is home to over 100 million people with diabetes and approximately 250 million classified as obese or overweight.[15] What makes the situation uniquely dangerous is the Thin-Fat Indian paradox: South Asians tend to accumulate more visceral (belly) fat, liver fat, and less lean muscle mass at lower body weights than Western populations.[8][9][10] While GLP-1 medications are a global phenomenon, they are particularly critical for the Thin-Fat Indian phenotype
Other observational studies have linked GLP-1 drugs to lower rates of new and recurring alcohol use disorder, reduced diagnoses and relapse in cannabis use disorder, fewer health care visits for nicotine dependence and lower risk of opioid overdose
Semaglutide has a half-life of approximately 7 days, meaning the medication persists in your bloodstream long enough that a one-day delay creates only a minor gap in drug concentration
I'm coming back for more
Luckily, the KD can maintain gut microbiota homeostasis
As a company dedicated to supplying high-purity, research-grade peptides, clarity and compliance are the cornerstones of our mission
